Raven Eric E J, Ottink Karsten D, Doets Kees C
Department of Orthopaedic Surgery and Traumatology, Gelre Hospital, Apeldoorn, The Netherlands.
J Hand Surg Am. 2012 Jan;37(1):55-62. doi: 10.1016/j.jhsa.2011.10.012. Epub 2011 Dec 3.
We evaluated long-term results for radiolunate and radioscapholunate arthrodeses for patients with rheumatoid or psoriatic arthritis to determine the durability and efficacy of the procedures. The results are described and compared with those in the literature.
We carried out arthrodesis of the radiolunate joint (33 wrists) and the radioscapholunate joint (13 wrists) to achieve pain reduction and ulnar translation of the carpus in patients with rheumatoid (42 wrists) or psoriatic arthritis (4 wrists). At follow-up, 11 patients (13 wrists) had died, 2 patients (4 wrists) were lost to follow-up, and in 6 wrists an additional midcarpal arthrodesis had been performed. We evaluated the remaining 23 wrists (19 radiolunate and 4 radioscapholunate, and 1 psoriatic arthritic wrist) after a mean of 11 years.
Clinical outcome was good, with a mean visual analog score of 2 out of 10 for pain, mean grip strength of 13 kg, and mean range of flexion-extension of 60°. Outcomes as measured by questionnaires were good. Radiographs demonstrated deterioration of all intracarpal joints as noted by an increased Larsen score and evidence of carpal translation. We noted no significant change in carpal height.
Despite radiographic progression, radiolunate and radioscapholunate arthrodeses yield good clinical results at long-term follow-up.
TYPE OF STUDY/LEVEL OF EVIDENCE: Therapeutic IV.
我们评估了类风湿性关节炎或银屑病关节炎患者行桡月关节和桡舟月关节融合术的长期效果,以确定该手术的耐用性和疗效。现将结果进行描述并与文献报道结果进行比较。
我们对类风湿性关节炎(42例腕关节)或银屑病关节炎(4例腕关节)患者进行了桡月关节融合术(33例腕关节)和桡舟月关节融合术(13例腕关节),以减轻疼痛并纠正腕骨尺侧移位。随访时,11例患者(13例腕关节)死亡,2例患者(4例腕关节)失访,6例腕关节进行了额外的中腕关节融合术。我们对平均随访11年后剩余的23例腕关节(19例桡月关节融合和4例桡舟月关节融合,以及1例银屑病关节炎腕关节)进行了评估。
临床结果良好,疼痛的视觉模拟评分为平均10分中的2分,平均握力为13 kg,平均屈伸范围为60°。问卷调查结果显示良好。X线片显示所有腕骨间关节均有退变,Larsen评分增加及腕骨移位迹象。我们发现腕骨高度无明显变化。
尽管X线片显示有进展,但桡月关节和桡舟月关节融合术在长期随访中仍能取得良好的临床效果。
研究类型/证据水平:治疗性IV级。